INTRODUCTION: PRKAG2 plays a role in regulating metabolic pathways, and mutations in this gene are associated with familial ventricular preexcitation, hypertrophic cardiomyopathy, and atrioventricular conduction disturbances. Clinico-pathologic and experimental data suggest the hypothesis of a glycogen storage disease. OBJECTIVE: To report a unique pattern of clinical features observed in individuals with a mutant PRKAG2 from two unrelated families. METHODS AND RESULTS: We studied two large families and found a total of 20 affected individuals showing a combination of sinus bradycardia, short PR interval, RBBB, intra and infrahisian conduction disturbances often requiring a pacemaker, and atrial tachyarrhythmias. Three individuals died suddenly at a young age. No patient had the Wolff-Parkinson-White (WPW) syndrome, and only two patients (10%) had myocardial hypertrophy. We performed screening of the exons and exon-intron boundaries of PRKAG2. Genetic analysis revealed a missense mutation (Arg302Gln) in the affected individuals from both families. This mutation had been described before and has been associated with the familial form of the WPW syndrome and with a high prevalence of left ventricular hypertrophy. CONCLUSION: PRKAG2 mutations are responsible for a diverse phenotype and not only the familial form of the WPW syndrome. Familial occurrence of right bundle branch block, sinus bradycardia, and short PR interval should raise suspicion of a mutant PRKAG2 gene.
INTRODUCTION:PRKAG2 plays a role in regulating metabolic pathways, and mutations in this gene are associated with familial ventricular preexcitation, hypertrophic cardiomyopathy, and atrioventricular conduction disturbances. Clinico-pathologic and experimental data suggest the hypothesis of a glycogen storage disease. OBJECTIVE: To report a unique pattern of clinical features observed in individuals with a mutant PRKAG2 from two unrelated families. METHODS AND RESULTS: We studied two large families and found a total of 20 affected individuals showing a combination of sinus bradycardia, short PR interval, RBBB, intra and infrahisian conduction disturbances often requiring a pacemaker, and atrial tachyarrhythmias. Three individuals died suddenly at a young age. No patient had the Wolff-Parkinson-White (WPW) syndrome, and only two patients (10%) had myocardial hypertrophy. We performed screening of the exons and exon-intron boundaries of PRKAG2. Genetic analysis revealed a missense mutation (Arg302Gln) in the affected individuals from both families. This mutation had been described before and has been associated with the familial form of the WPW syndrome and with a high prevalence of left ventricular hypertrophy. CONCLUSION:PRKAG2 mutations are responsible for a diverse phenotype and not only the familial form of the WPW syndrome. Familial occurrence of right bundle branch block, sinus bradycardia, and short PR interval should raise suspicion of a mutant PRKAG2 gene.
Authors: Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra Journal: Circ Arrhythm Electrophysiol Date: 2016-01
Authors: Andrés Ricardo Pérez-Riera; Augusto Armando de Lucca; Raimundo Barbosa-Barros; Frank G Yanowitz; Silvia Fortunato de Cano; Manuel Nicolás Cano; Antônio Carlos Palandri-Chagas Journal: Ann Noninvasive Electrocardiol Date: 2013-07 Impact factor: 1.468
Authors: Emanuele Monda; Marta Rubino; Michele Lioncino; Francesco Di Fraia; Roberta Pacileo; Federica Verrillo; Annapaola Cirillo; Martina Caiazza; Adelaide Fusco; Augusto Esposito; Fabio Fimiani; Giuseppe Palmiero; Giuseppe Pacileo; Paolo Calabrò; Maria Giovanna Russo; Giuseppe Limongelli Journal: Front Pediatr Date: 2021-02-25 Impact factor: 3.569
Authors: Luiz Pereira de Magalhães; Eduardo Faria Soares de Magalhães; Jussara de Oliveira Pinheiro; Alex Teixeira Guabiru; Francisco José Farias Borges Dos Reis; Roque Aras Journal: Arq Bras Cardiol Date: 2022-01 Impact factor: 2.000
Authors: Arash Yavari; Claire J Stocker; Sahar Ghaffari; Edward T Wargent; Violetta Steeples; Gabor Czibik; Katalin Pinter; Mohamed Bellahcene; Angela Woods; Pablo B Martínez de Morentin; Céline Cansell; Brian Y H Lam; André Chuster; Kasparas Petkevicius; Marie-Sophie Nguyen-Tu; Aida Martinez-Sanchez; Timothy J Pullen; Peter L Oliver; Alexander Stockenhuber; Chinh Nguyen; Merzaka Lazdam; Jacqueline F O'Dowd; Parvathy Harikumar; Mónika Tóth; Craig Beall; Theodosios Kyriakou; Julia Parnis; Dhruv Sarma; George Katritsis; Diana D J Wortmann; Andrew R Harper; Laurence A Brown; Robin Willows; Silvia Gandra; Victor Poncio; Márcio J de Oliveira Figueiredo; Nathan R Qi; Stuart N Peirson; Rory J McCrimmon; Balázs Gereben; László Tretter; Csaba Fekete; Charles Redwood; Giles S H Yeo; Lora K Heisler; Guy A Rutter; Mark A Smith; Dominic J Withers; David Carling; Eduardo B Sternick; Jonathan R S Arch; Michael A Cawthorne; Hugh Watkins; Houman Ashrafian Journal: Cell Metab Date: 2016-04-28 Impact factor: 27.287